A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : EIAV / equine infectious anemia virus

[Related PubMed/MEDLINE]
Total Number of Papers: 540
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   EIAV  (>> Co-occurring Abbreviation)
Long Form:   equine infectious anemia virus
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2023 Serological evidence of circulation of West Nile virus in equids in Algerian eastern drylands and its epidemiological risk factors. USUV, VNT, WNV
2022 A Novel, Fully Spliced, Accessory Gene in Equine Lentivirus with Distinct Rev-Responsive Element. CRM1, RRE
2022 Coupling spatial statistics with social network analysis to estimate distinct risk areas of disease circulation to improve risk-based surveillance. ---
2022 Identification of a Novel Post-transcriptional Transactivator from the Equine Infectious Anemia Virus. aa, BiFC, Co-IP, CRM1, RRE, RT-PCR
2022 Low transmission rates of Equine infectious anemia virus (EIAV) in foals born to seropositive feral mares inhabiting the Amazon delta region despite climatic conditions supporting high insect vector populations. AGID
2022 MX2 Viral Substrate Breadth and Inhibitory Activity Are Regulated by Protein Phosphorylation. HIV-1, MLV
2022 Serological cross-sectional survey of equine infectious anemia in Saudi Arabia. EIA
2022 SYNJ2BP Improves the Production of Lentiviral Envelope Protein by Facilitating the Formation of Mitochondrion-Associated Endoplasmic Reticulum Membrane. ER, ERAD, MAM
2022 The Emerging Role of the Serine Incorporator Protein Family in Regulating Viral Infection. HBV, HIV, MLV, SERINC
10  2021 Effect of Small Polyanions on In Vitro Assembly of Selected Members of Alpha-, Beta- and Gammaretroviruses. MLV, MPMV, RSV
11  2021 Equine Infectious Anemia Virus (EIAV): Evidence of Circulation in Donkeys from the Brazilian Northeast Region. AGID, EIA, ELISA, OIE, PCR, rgp90, rp26
12  2021 Identification and genetic characterization of equine infectious anemia virus in Western Balkans. AGID, EIA, ELISA
13  2021 Impact of changes of horse movement regulations on the risks of equine infectious anemia: A risk assessment approach. ---
14  2021 Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity. A-MLV, HIV-1, IAV, MLV, MPMV, PIV5, RABV, VSV-G
15  2021 Modelling Mutation in Equine Infectious Anemia Virus Infection Suggests a Path to Viral Clearance with Repeated Vaccination. ---
16  2021 Molecular detection of equine infectious anemia virus in clinically normal, seronegative horses in an endemic area of Mexico. AGID, EIA
17  2021 Truncation of the Cytoplasmic Tail of Equine Infectious Anemia Virus Increases Virion Production by Improving Env Cleavage and Plasma Membrane Localization. CT, CTs, Env, Envs, PM, SU, TM
18  2020 A Conserved Acidic-Cluster Motif in SERINC5 Confers Partial Resistance to Antagonism by HIV-1 Nef. glycoGag, HIV-1, MLV
19  2020 Comparative analysis of CpG islands in equine infectious anemia virus strains. ---
20  2020 Equine lentivirus counteracts SAMHD1 restriction by Rev-mediated degradation of SAMHD1 via the BECN1-dependent lysosomal pathway. BECN1
21  2020 High Genomic Variability in Equine Infectious Anemia Virus Obtained from Naturally Infected Horses in Pantanal, Brazil: An Endemic Region Case. EIA, NGS
22  2020 Identification of large genetic variations in the equine infectious anemia virus tat-gag genomic region. AGID, EIA, ELISAs, tat-gag
23  2020 Molecular Characterization of the Major Open Reading Frames (ORFs) and Enhancer Elements From Four Geographically Distinct North American Equine Infectious Anemia Virus (EIAV) Isolates. EIAVPA, LTRs, ORFs, ORFs
24  2020 Molecular detection, histopathological analysis, and immunohistochemical characterization of equine infectious anemia virus in naturally infected equids. EIA
25  2020 SERINC5 Potently Restricts Retrovirus Infection In Vivo. glycoGag, HIV, HIV-1, MLV, mSERINC5, SERINC
26  2020 Structures of immature EIAV Gag lattices reveal a conserved role for IP6 in lentivirus assembly. CA, VLPs
27  2019 A PLPPV sequence in the p8 region of Gag provides late domain function for mouse mammary tumor virus. MMTV
28  2019 Attenuation of Equine Lentivirus Alters Mitochondrial Protein Expression Profile from Inflammation to Apoptosis. eMDMs
29  2019 Characterization of EIAV env Quasispecies during Long-Term Passage In Vitro: Gradual Loss of Pathogenicity. SGA
30  2019 HIV Vaccine Mystery and Viral Shell Disorder. HCV, HIV, HSV
31  2019 Molecular characterization of equine infectious anaemia virus strains detected in England in 2010 and 2012. ---
32  2019 Molecular characterization of Equine Infectious Anemia Viruses using targeted sequence enrichment and next generation sequencing. ---
33  2019 Surveillance of the equine infectious anemia virus in Eastern and Central Saudi Arabia during 2014-2016. KSA
34  2019 The Conserved Tyr176/Leu177 Motif in the alpha-Helix 9 of the Feline Immunodeficiency Virus Capsid Protein Is Critical for Gag Particle Assembly. CA, FIV
35  2019 The retroviral accessory proteins S2, Nef, and glycoMA use similar mechanisms for antagonizing the host restriction factor SERINC5. BiFC, eSERINC5, IP, MLV, SERINC5
36  2019 Thermostable properties of the equine infectious anemia virus nucleocapsid protein NCp11. NC
37  2018 Characterization of Equine Infectious Anemia Virus Long Terminal Repeat Quasispecies In Vitro and In Vivo. EHR, LTR, NRE, TAR, TSS
38  2018 Equine infectious anemia virus in naturally infected horses from the Brazilian Pantanal. AGID, EIA, snPCR
39  2018 Equine MX2 is a restriction factor of equine infectious anemia virus (EIAV). eMX2, hMXB
40  2018 Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein. eMDMs, eqMx2, HIV-1, IFN, MLV, SIVs
41  2018 Prospects in Innate Immune Responses as Potential Control Strategies against Non-Primate Lentiviruses. BIV, PAMPs, PRRs, SRLV
42  2018 The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists. HIV, MLV, SERINC3, VSV-G
43  2017 Clues for two-step virion infectivity factor regulation by core binding factor beta. CBFbeta, SIVmac, Vif
44  2017 Covalent conjugation of the equine infectious anemia virus Gag with SUMO. SUMO
45  2017 Deep sequencing and variant analysis of an Italian pathogenic field strain of equine infectious anaemia virus. NGS, ORFs
46  2017 Detection of West Nile Virus and other common equine viruses in three locations from the Leeward Islands, West Indies. EI, EVA, WNV
47  2017 Dynamics of lentiviral infection in vivo in the absence of adaptive immune responses. SCID
48  2017 Equine infectious anemia prevalence in feral donkeys from Northeast Brazil. IB
49  2017 Molecular characterization of bovine leukemia virus from Moldovan dairy cattle. BLV, EBL, HIV
50  2017 Molecular characterization of equine infectious anaemia virus from a major outbreak in southeastern France. EIA
51  2017 Nonsynonymous changes of equine lentivirus receptor-1 (ELR1) gene in amino acids involved in the interaction with equine infectious anemia virus (EIAV). ELR1, SNPs, TNFRSF14
52  2017 The integration of a macrophage-adapted live vaccine strain of equine infectious anaemia virus (EIAV) in the horse genome. FED, GO, IS, KEGG, LINEs, MDMs, RefSeq
53  2016 A pilot study on interaction between donkey tetherin and EIAV stains with different virulent and replication characteristics. do-tetherin, Env
54  2016 Comparison of Antibody Immune responses to different HIV-1 Envelope Glycoprotein Mutants. HIV-1
55  2016 Double-stranded-RNA-specific adenosine deaminase 1 (ADAR1) is proposed to contribute to the adaptation of equine infectious anemia virus from horses to donkeys. EIA
56  2016 Equine schlafen 11 restricts the production of equine infectious anemia virus via a codon usage-dependent mechanism. eSLFN11, RSCU
57  2016 Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins. MLVs
58  2016 Genetic Evolution during the development of an attenuated EIAV vaccine. ---
59  2016 Health and epidemiological approaches of Trypanosoma evansi and equine infectious anemia virus in naturally infected horses at southern Pantanal. ---
60  2016 Horses naturally infected with EIAV harbor 2 distinct SU populations but are monophyletic with respect to IN. IN, LTR, SU
61  2016 Identification and characterization of a common B-cell epitope on EIAV capsid proteins. AC-ELISA, mAbs
62  2016 Infection with equine infectious anemia virus vaccine strain EIAVDLV121 causes no visible histopathological lesions in target organs in association with restricted viral replication and unique cytokine response. ---
63  2016 Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study. AE, GEM, nvAMD, TU
64  2016 Optimizing Transgene Configuration and Protein Fusions to Maximize Dopamine Production for the Gene Therapy of Parkinson's Disease. LV, PD
65  2016 Regulation of Rev expression by the equine infectious anaemia virus tat-rev mRNA Kozak sequence and its potential influence on viral replication. ---
66  2016 S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3. AP2, Nef, SERINC
67  2016 Serologically silent, occult equine infectious anemia virus (EIAV) infections in horses. OIE
68  2016 Structural and functional characterization of EIAV gp45 fusion peptide proximal region and asparagine-rich layer. FPPR, HIV
69  2015 ALG-2 activates the MVB sorting function of ALIX through relieving its intramolecular interaction. EGFR, ESCRT, MVB
70  2015 Characterization of Equine Infectious Anemia Virus Integration in the Horse Genome. FED, HIV, LINEs, SINEs, TSS
71  2015 Double-stranded RNA-specific adenosine deaminase 1 (ADAR1) promotes EIAV replication and infectivity. ADARs, eADAR1, HIV, LTR, RRE
72  2015 Equine Infectious Anemia Virus Gag Assembly and Export Are Directed by Matrix Protein through trans-Golgi Networks and Cellular Vesicles. MA, PM, TGN
73  2015 Free-virus and cell-to-cell transmission in models of equine infectious anemia virus infection. IFE, ODEs
74  2015 Freedom from equine infectious anaemia virus infection in Spanish Purebred horses. EIA, SP
75  2015 Insights into vaccine development for acquired immune deficiency syndrome from crystal structures of human immunodeficiency virus-1 gp41 and equine infectious anemia virus gp45. ---
76  2015 Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection. eCT1, ELR1, eTat, LTR, MEFs, RT-PCR, TNFR
77  2015 Proteomic alteration of equine monocyte-derived macrophages infected with equine infectious anemia virus. HIV, KEGG, PRM, SIV
78  2015 Structural insight into equine lentivirus receptor 1. AUC, CRD1, ELR1, ITC
79  2015 The efficacy of ELISA commercial kits for the screening of equine infectious anemia virus infection. ---
80  2014 A unique evolution of the s2 gene of equine infectious anemia virus in hosts correlated with particular infection statuses. ---
81  2014 Antiviral potency and functional analysis of tetherin orthologues encoded by horse and donkey. ---
82  2014 Comparative analysis of LTR and structural genes in an equine infectious anemia virus strain isolated from a feral horse in Japan. LTRs
83  2014 Computational modeling suggests dimerization of equine infectious anemia virus Rev is required for RNA binding. RRE
84  2014 Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation. BIV, CAEV, CBF-beta, FIV, MVV, Vif
85  2014 Development of antigencapture ELISA for the quantification of EIAV p26 protein. AC-ELISA, HRP, mAbs, RT, WB
86  2014 Development, evaluation, and laboratory validation of immunoassays for the diagnosis of equine infectious anemia (EIA) using recombinant protein produced from a synthetic p26 gene of EIA virus. AGID, EIA, ELISA
87  2014 Effects of human SAMHD1 polymorphisms on HIV-1 susceptibility. ---
88  2014 Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum. eMDMs, ER, eViperin, SAM
89  2014 Evolution of the retroviral restriction gene Fv1: inhibition of non-MLV retroviruses. ERV, FFV, MLV
90  2014 High genetic diversity of equine infectious anaemia virus strains from Slovenia revealed upon phylogenetic analysis of the p15 gag gene region. ---
91  2014 Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus. SCID
92  2014 Infection of equine monocyte-derived macrophages with an attenuated equine infectious anemia virus (EIAV) strain induces a strong resistance to the infection by a virulent EIAV strain. EMDM, IFNbeta, TLR3
93  2014 Prevalence of antibodies against influenza virus in non-vaccinated equines from the Brazilian Pantanal. EIV
94  2014 Serosurveillance of infectious agents in equines of the Central Valley of Costa Rica. EVAV, IAV, WNV
95  2014 Structural and biochemical insights into the V/I505T mutation found in the EIAV gp45 vaccine strain. HIV
96  2014 Suppression of neovascularization of donor corneas by transduction with equine infectious anemia virus-based lentiviral vectors expressing endostatin and angiostatin. ---
97  2014 The dUTPase-related gene of bovine immunodeficiency virus is critical for viral replication, despite the lack of dUTPase activity of the encoded protein. BIV, dUTPases, WT
98  2014 Use of heavy water (D2O) in developing thermostable recombinant p26 protein based enzyme-linked immunosorbent assay for serodiagnosis of equine infectious anemia virus infection. ELISA
99  2013 Amplification of complete gag gene sequences from geographically distinct equine infectious anemia virus isolates. ---
100  2013 Comprehensive analysis of the overall codon usage patterns in equine infectious anemia virus. CAI, ENC